BioProtect is an international medical device startup engaged in developing biodegradable balloon spacers for radiation therapy.
Bioprotect has raised €33M across 2 funding rounds, most recently a Series D+ round in Sep 2020. Based in Tsur Moshe, Israel; founded 2004; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-09-22 | Series D+ | €21M | — | View deal → |
| 2020-01-01 | Series D+ | €12M | — | View deal → |
